Get started
Author

Rumaisa Riaz

Observed names: R Riaz, rumaisa riaz
Observed institution: Dow University of Health Sciences
ORCID: 0000-0002-2277-0183
Observed ORCID: 0000-0002-2277-0183
OpenAlex ID: A5076917460
Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa
2023 · Afsheen Khan, Rumaisa Riaz, et al. · Annals of Medicine and Surgery · 36
Role of gut microbiota in the pathogenesis of metabolic syndrome: an updated comprehensive review from mechanisms to clinical implications
2025 · Ajeet Singh, Amogh Verma, et al. · Annals of Medicine and Surgery · 17
Integrating mental health and cardiovascular wellness: synergistic impacts and the promise of comprehensive care models
2025 · Ajeet Singh, Rumaisa Riaz, et al. · Annals of Medicine and Surgery · 15
Noninvasive diagnostic biomarkers, genomic profiling, and advanced microscopic imaging in the early detection and characterization of Naegleria fowleri infections leading to primary amebic meningoencephalitis (PAM)
2024 · Ayesha Shaukat, Nawal Khaliq, et al. · Annals of Medicine and Surgery · 15
Elrexfio™ (elranatamab-bcmm): The game-changer in treatment of multiple myeloma
2023 · Taruba Rais, Afsheen Khan, et al. · Rare Tumors · 13
The efficacy and safety of nelarabine in relapsed or refractory T-cell acute lymphoblastic leukemia: a systematic review and meta-analysis
2025 · Laiba Shakeel, Nawal Khaliq, et al. · Annals of Hematology · 6
PDF
Innovations in colorectal cancer treatment: trifluridine and tipiracil with bevacizumab for improved outcomes – a review
2024 · Taruba Rais, Rumaisa Riaz, et al. · Frontiers in Oncology · 6
Epcoritamab-bysp (Epkinly) – A phenomenal breakthrough in the treatment of diffuse large B-cell lymphoma
2023 · Rumaisa Riaz, Afsheen Khan, et al. · Rare Tumors · 6
PDF
Mosquito-borne diseases in Pakistan: challenges, strategies, and future prospects
2023 · Tehreem Fatima, Ashna Habib, et al. · International Journal of Surgery Global Health · 5
Japanese encephlu emergence in Australia: the potential population at risk
2024 · Afsheen Khan, Rumaisa Riaz, et al. · Annals of Medicine and Surgery · 4
“The efficacy and safety of Atogepant for migraine prophylaxis: a systematic review and meta-analysis of randomized controlled trials”
2025 · Ayesha Shaukat, Laiba Shakeel, et al. · BMC Neurology · 3
PDF
Retifanlimab: a breakthrough for the management of Merkel cell carcinoma
2023 · Ayesha Shaukat, Afsheen Khan, et al. · International Journal of Surgery Oncology · 3
Radiofrequency ablation versus laparoscopic adrenalectomy for aldosterone-producing adenomas: a systematic review and meta-analysis
2025 · Abdullah Nadeem, Tasmiyah Siddiqui, et al. · Endocrine · 2
Aprocitentan in hypertension management: clinical efficacy, safety, and future prospects
2025 · Rumaisa Riaz, Usaid Ahmed, et al. · Annals of Medicine and Surgery · 2
Efficacy of once‐weekly insulin efsitora versus once‐daily basal insulin in type 2 diabetes: A systematic review and meta‐analysis
2026 · Mariam Akmal, Sheharyar Tariq, et al. · Diabetes Obesity and Metabolism · 1
PDF
Unusual Etiology of Budd‐Chiari Syndrome in an Adolescent: A Case of Combined Thrombophilic Disorder
2025 · Santosh Sah, Rumaisa Riaz, et al. · Clinical Case Reports · 1
PDF
River blindness: a devastating yet neglected tropical disease in Africa
2025 · Abdullahi Tunde Aborode, Rumaisa Riaz, et al. · Annals of Medicine and Surgery · 1
‘Ritlecitinib: unveiling hair regrowth for alopecia areata’
2024 · Nawal Khaliq, Rumaisa Riaz, et al. · Annals of Medicine and Surgery · 1
Pombiliti and Opfolda: shaping the future of adult late-onset pompe disease: an editorial
2024 · Rumaisa Riaz, Ajeet Singh, et al. · Annals of Medicine and Surgery · 1
Ryzumvi: pioneering advances in countering drug-induced mydriasis
2024 · Ayesha Azhar, Rumaisa Riaz, et al. · Annals of Medicine and Surgery · 1
The current state of neurosurgical care in Africa - a correspondence
2024 · Malik Olatunde Oduoye, Rumaisa Riaz, et al. · Neurosurgical Review · 1
Evaluating the therapeutic efficacy of SKYCLARYS: a promising FDA-approved drug for Friedreich ataxia treatment
2024 · Usaid Ahmed, Laiba Afaq, et al. · International Journal of Surgery Global Health · 1
Zurzuvae: A paradigm shift in postpartum depression treatment
2023 · Abdullah Nadeem, Um E Abiha Batool, et al. · Asian Journal of Psychiatry · 1
Assessing the benefits and drawbacks of cryolipolysis as a noninvasive body sculpting technique: risks, side effects, and future research – an editorial
2023 · Tooba Ali, Ashna Habib, et al. · International Journal of Surgery Global Health · 1
FDA Approval of Donanemab‐azbt: A New Dawn in Alzheimer's Disease Treatment
2026 · Rumaisa Riaz, Marrium Fatima, et al. · Health Science Reports
Works count: 40
Citation count: 142
H-index: 6
I10-index: 5
Year
Topic
Type